GILUPI

GILUPI is a company headquartered in Germany that develops medical devices for isolating rare cells from circulating blood in vivo. The company develops and sells diagnostic and therapeutic products based on nanotechnology for the detection and treatment of diseases. It has developed a device designed to specifically isolate tumor cells from a patient’s circulating blood through the predetermined selectivity of antibodies bound to nanodetectors.